Valeo Financial Advisors LLC Purchases Shares of 199 Mettler-Toledo International, Inc. $MTD

Valeo Financial Advisors LLC purchased a new stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 199 shares of the medical instruments supplier’s stock, valued at approximately $234,000.

A number of other hedge funds have also made changes to their positions in the business. Park Avenue Securities LLC increased its holdings in Mettler-Toledo International by 7.2% in the 1st quarter. Park Avenue Securities LLC now owns 297 shares of the medical instruments supplier’s stock valued at $351,000 after purchasing an additional 20 shares in the last quarter. Farther Finance Advisors LLC boosted its position in shares of Mettler-Toledo International by 39.1% in the first quarter. Farther Finance Advisors LLC now owns 89 shares of the medical instruments supplier’s stock worth $103,000 after buying an additional 25 shares during the period. GAMMA Investing LLC boosted its position in shares of Mettler-Toledo International by 11.2% in the first quarter. GAMMA Investing LLC now owns 327 shares of the medical instruments supplier’s stock worth $386,000 after buying an additional 33 shares during the period. CX Institutional acquired a new position in Mettler-Toledo International during the 1st quarter worth approximately $175,000. Finally, Simon Quick Advisors LLC lifted its position in Mettler-Toledo International by 136.3% during the 1st quarter. Simon Quick Advisors LLC now owns 397 shares of the medical instruments supplier’s stock worth $469,000 after acquiring an additional 229 shares in the last quarter. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Stock Performance

Shares of Mettler-Toledo International stock opened at $1,274.39 on Friday. The firm has a market cap of $26.25 billion, a PE ratio of 32.27, a price-to-earnings-growth ratio of 3.92 and a beta of 1.37. The firm’s 50-day simple moving average is $1,278.97 and its 200-day simple moving average is $1,190.04. Mettler-Toledo International, Inc. has a 1 year low of $946.69 and a 1 year high of $1,486.76.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings data on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share for the quarter, beating the consensus estimate of $9.58 by $0.51. The firm had revenue of $983.22 million during the quarter, compared to analyst estimates of $957.41 million. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.Mettler-Toledo International’s quarterly revenue was up 3.9% on a year-over-year basis. During the same period in the previous year, the company earned $9.65 earnings per share. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. On average, equities analysts predict that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

Insider Transactions at Mettler-Toledo International

In other news, insider Gerry Keller sold 165 shares of Mettler-Toledo International stock in a transaction that occurred on Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total value of $215,925.60. Following the completion of the transaction, the insider owned 94 shares in the company, valued at approximately $123,012.16. This trade represents a 63.71% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Shawn Vadala sold 300 shares of the firm’s stock in a transaction on Friday, August 8th. The stock was sold at an average price of $1,254.09, for a total value of $376,227.00. Following the transaction, the chief financial officer owned 5,095 shares in the company, valued at $6,389,588.55. This trade represents a 5.56% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 1,827 shares of company stock worth $2,371,208. 1.94% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on MTD. Evercore ISI lifted their price objective on shares of Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the company an “outperform” rating in a research note on Tuesday. JPMorgan Chase & Co. raised their price target on shares of Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the company a “neutral” rating in a report on Thursday. Barclays raised their price target on shares of Mettler-Toledo International from $1,325.00 to $1,350.00 and gave the company an “overweight” rating in a report on Thursday, October 2nd. Weiss Ratings reissued a “hold (c)” rating on shares of Mettler-Toledo International in a research report on Wednesday. Finally, Citigroup boosted their price target on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a “buy” rating in a research note on Thursday, August 21st. Five analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $1,336.50.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.